查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1672082

全球醫療合約研究外包市場研究報告-產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Healthcare Contract Research Outsourcing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

全球醫療保健合約研究外包市場規模預計將從 2024 年的 572.1 億美元成長到 2033 年的 1075.8 億美元，在 2026 年至 2033 年的預測期內呈現 7.27% 的強勁年複合成長率(CAGR)。

受臨床研究和藥物開發對高效且經濟實惠的解決方案的需求不斷成長的推動，醫療合約研究外包（CRO）市場有望大幅成長。隨著製藥和生技公司尋求簡化營運流程、縮短新療法的上市時間，對 CRO 的專業知識和資源的依賴也變得越來越普遍。隨著各組織致力於增強其研究能力，市場對各種服務的需求激增，包括臨床試驗管理、資料分析和監管支援。

技術和資料管理的創新正在塑造醫療保健 CRO 市場的未來。進階分析、人工智慧和機器學習的整合使 CRO 能夠最佳化臨床試驗設計、改善患者招募並增強資料完整性。此外，分散臨床試驗和遠端監控解決方案的興起正在改變研究的進行方式，使得資料收集更加靈活、高效。隨著監管環境的發展，CRO 越來越注重合規性和品質保證，以滿足衛生當局的嚴格要求。

此外，醫療保健 CRO 市場將受益於 CRO、製藥公司和學術機構之間加強合作，以促進創新並改善研究成果。隨著情勢的發展，重點將轉向發展策略夥伴關係，利用每個利害關係人的優勢，提高藥物開發過程的整體效率。以患者為中心的方法和真實世界證據的重視也將在塑造醫療保健 CRO 服務的未來方面發揮關鍵作用，確保臨床研究符合患者的需求和偏好。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

報告涵蓋的細分

按服務

  • 臨床試驗服務
  • 監管服務
  • 臨床數據管理和生物識別
  • 醫學寫作
  • 藥物警戒
  • 站點管理協議
  • 其他

按治療領域

  • 腫瘤科/血液科
  • 細胞分裂素
  • 心血管/代謝
  • 呼吸系統
  • 傳染病
  • 免疫學
  • 罕見疾病
  • 醫療設備
  • 其他

按最終用戶

  • 製藥公司
  • 生技公司
  • 醫療器材公司
  • 學術機構和政府組織
  • 公司簡介
  • Syneos 健康
  • 精鼎國際
  • ICON 集團
  • PRA 健康科學公司
  • 查爾斯河
  • 美國實驗室控股公司（Covance）
  • 艾昆緯
  • 梅德佩斯
  • 醫藥產品開發有限公司。
  • 以上清單可以自訂。

目錄

第 1 章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第3章：醫療合約研究外包產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 各服務市場吸引力分析
    • 按治療領域進行的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球醫療保健合約研究外包市場分析：按服務

  • 服務概覽
  • 按服務進行的歷史和預測資料分析
  • 臨床試驗服務
  • 監管服務
  • 臨床數據管理和生物識別
  • 醫學寫作
  • 藥物警戒
  • 站點管理協議
  • 其他

第6章：全球醫療保健合約研究外包市場分析：依治療領域

  • 按治療領域概述
  • 按治療領域分類的歷史和預測數據分析
  • 腫瘤科/血液科
  • 細胞分裂素
  • 心血管/代謝
  • 呼吸系統
  • 傳染病
  • 免疫學
  • 罕見疾病
  • 醫療設備
  • 其他

第 7 章：全球醫療保健合約研究外包市場分析：按最終用戶

  • 最終用戶概覽
  • 最終用戶的歷史和預測數據分析
  • 製藥公司
  • 生技公司
  • 醫療器材公司
  • 學術機構和政府組織

第 8 章：全球醫療保健合約研究外包市場分析：按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第9章：醫療合約研究外包公司的競爭格局

  • 醫療保健合約研究外包市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第10章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Syneos Health
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PAREXEL International
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • ICON Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PRA Health Sciences Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Charles River
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Laboratory Corporation Of America Holdings (Covance)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • IQVIA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Medpace
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Pharmaceutical Product Development LLC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR11215366

Global Healthcare Contract Research Outsourcing Market size is anticipated to grow from USD 57.21 Billion in 2024 to USD 107.58 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.27% during the forecast period of 2026 to 2033.

The healthcare contract research outsourcing (CRO) market is poised for substantial growth, driven by the increasing demand for efficient and cost-effective solutions in clinical research and drug development. As pharmaceutical and biotechnology companies seek to streamline their operations and reduce time-to-market for new therapies, the reliance on CROs for specialized expertise and resources is becoming more prevalent. The market is witnessing a surge in demand for a wide range of services, including clinical trial management, data analysis, and regulatory support, as organizations aim to enhance their research capabilities.

Innovations in technology and data management are shaping the future of the healthcare CRO market. The integration of advanced analytics, artificial intelligence, and machine learning is enabling CROs to optimize clinical trial designs, improve patient recruitment, and enhance data integrity. Additionally, the rise of decentralized clinical trials and remote monitoring solutions is transforming the way research is conducted, allowing for greater flexibility and efficiency in data collection. As regulatory environments evolve, CROs are increasingly focusing on compliance and quality assurance to meet the stringent requirements of health authorities.

Moreover, the healthcare CRO market will benefit from increased collaboration between CROs, pharmaceutical companies, and academic institutions to foster innovation and improve research outcomes. As the landscape evolves, the focus will shift towards developing strategic partnerships that leverage the strengths of each stakeholder, enhancing the overall efficiency of the drug development process. The emphasis on patient-centric approaches and real-world evidence will also play a crucial role in shaping the future of healthcare CRO services, ensuring that clinical research aligns with the needs and preferences of patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Service

  • Clinical Trial Service
  • Regulatory Service
  • Clinical Data Management & Biometrics
  • Medical Writing
  • Pharmacovigilance
  • Site Management Protocol
  • Others

By Therapeutic Area

  • Oncology / Hematology
  • CNs
  • CV/Metabolic
  • Respiratory
  • Infectious Diseases
  • Immunology
  • Rare Diseases
  • Medical Devices
  • Others

By End-user

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Academic Institutes & Government Organizations
  • COMPANIES PROFILED
  • Syneos Health
  • PAREXEL International
  • ICON plc
  • PRA Health Sciences Inc.
  • Charles River
  • Laboratory Corporation of America Holdings (Covance)
  • IQVIA
  • Medpace
  • Pharmaceutical Product Development LLC.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY SERVICE

  • 5.1. Overview By Service
  • 5.2. Historical and Forecast Data Analysis By Service
  • 5.3. Clinical Trial Service Historic and Forecast Sales By Regions
  • 5.4. Regulatory Service Historic and Forecast Sales By Regions
  • 5.5. Clinical Data Management & Biometrics Historic and Forecast Sales By Regions
  • 5.6. Medical Writing Historic and Forecast Sales By Regions
  • 5.7. Pharmacovigilance Historic and Forecast Sales By Regions
  • 5.8. Site Management Protocol Historic and Forecast Sales By Regions
  • 5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1. Overview By Therapeutic Area
  • 6.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 6.3. Oncology / Hematology Historic and Forecast Sales By Regions
  • 6.4. CNs Historic and Forecast Sales By Regions
  • 6.5. CV/Metabolic Historic and Forecast Sales By Regions
  • 6.6. Respiratory Historic and Forecast Sales By Regions
  • 6.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 6.8. Immunology Historic and Forecast Sales By Regions
  • 6.9. Rare Diseases Historic and Forecast Sales By Regions
  • 6.10. Medical Devices Historic and Forecast Sales By Regions
  • 6.11. Others Historic and Forecast Sales By Regions

7. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.4. Biotechnology Companies Historic and Forecast Sales By Regions
  • 7.5. Medical Device Companies Historic and Forecast Sales By Regions
  • 7.6. Academic Institutes & Government Organizations Historic and Forecast Sales By Regions

8. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HEALTHCARE CONTRACT RESEARCH OUTSOURCING COMPANIES

  • 9.1. Healthcare Contract Research Outsourcing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Syneos Health
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. PAREXEL International
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. ICON Plc
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. PRA Health Sciences Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Charles River
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Laboratory Corporation Of America Holdings (Covance)
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. IQVIA
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Medpace
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Pharmaceutical Product Development LLC
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service (USD MN)
  • Clinical Trial Service Market Sales By Geography (USD MN)
  • Regulatory Service Market Sales By Geography (USD MN)
  • Clinical Data Management & Biometrics Market Sales By Geography (USD MN)
  • Medical Writing Market Sales By Geography (USD MN)
  • Pharmacovigilance Market Sales By Geography (USD MN)
  • Site Management Protocol Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology / Hematology Market Sales By Geography (USD MN)
  • CNs Market Sales By Geography (USD MN)
  • CV/Metabolic Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Medical Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Biotechnology Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic Institutes & Government Organizations Market Sales By Geography (USD MN)
  • Global Healthcare Contract Research Outsourcing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Healthcare Contract Research Outsourcing Report
  • Market Research Process
  • Market Research Methodology
  • Global Healthcare Contract Research Outsourcing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Service (USD MN)
  • Clinical Trial Service Market Sales By Geography (USD MN)
  • Regulatory Service Market Sales By Geography (USD MN)
  • Clinical Data Management & Biometrics Market Sales By Geography (USD MN)
  • Medical Writing Market Sales By Geography (USD MN)
  • Pharmacovigilance Market Sales By Geography (USD MN)
  • Site Management Protocol Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology / Hematology Market Sales By Geography (USD MN)
  • CNs Market Sales By Geography (USD MN)
  • CV/Metabolic Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Medical Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Biotechnology Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic Institutes & Government Organizations Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.